Premium
Use of Bromodeoxyuridine, Proliferating Cell Nuclear Antigen, and Nucleolar Organizer Regions in the Multiparametric Assessment of Proliferating Potency in Cervical Intraepithelial Neoplasia
Author(s) -
Kaneko Shigenobu,
Izutsu Toshihiko
Publication year - 1995
Publication title -
journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.597
H-Index - 50
eISSN - 1447-0756
pISSN - 1340-9654
DOI - 10.1111/j.1447-0756.1995.tb01086.x
Subject(s) - dysplasia , cervical intraepithelial neoplasia , carcinoma in situ , proliferating cell nuclear antigen , bromodeoxyuridine , intraepithelial neoplasia , pathology , nucleolus organizer region , biology , epithelium , antigen , carcinoma , medicine , cervical cancer , nucleolus , cancer , immunohistochemistry , immunology , prostate , biochemistry , cytoplasm , genetics
The authors analysed of the proliferative activity of intraepithelial neoplasia of the cervix utilizing the labeling index of monoclonal antibody to Bromodeoxyuridine (BrdU) or proliferating cell nuclear antigen (PCNA), and the number of Nucleolar organizer regions (Ag‐NOR). The BrdU labeling index (B.L.I.) for normal squamous epithelium, mild dysplasia, and moderate dysplasia were significantly lower than for severe dysplasia or carcinoma in situ. The PCNA labeling index (P.L.I.) for normal squamous epithelium, mild dysplasia, and moderate dysplasia were significantly lower than for severe dysolasia or carcinoma in situ. The number of Ag‐NOR dots of normal squamous epithelium and mild dysplasia were lower than those of severe dysplasia or carcinoma in situ. There are significantly positive correlations of the B.L.I., P.L.I., and the number of Ag‐NORs in cervical intraepithelial neoplasia.